All articles by Srivani Venna

  1. Theravance and Mylan expand agreement for nebulised revefenacin

    Theravance Biopharma Ireland and Mylan have expanded their existing development and commercialisation agreement for nebulised revefenacin. The latest agreement will…
    Read More…

    17 Jun
  2. Amgen and Allergan secure US FDA approval for Herceptin biosimilar

    The US Food and Drug Administration (FDA) has approved Amgen and Allergan’s Kanjinti (trastuzumab-anns). The drug is a biosimilar to…
    Read More…

    17 Jun
  3. Janssen to use Iktos’ AI technology for drug discovery

    Janssen Pharmaceutica has initiated a collaboration agreement to use Iktos’ artificial intelligence (AI) technology to accelerate small molecule drug discovery….
    Read More…

    30 Apr
  4. FDA approves Benlysta to treat children with SLE

    The US Food and Drug Administration has approved GlaxoSmithKline’s Benlysta (belimumab) intravenous (IV) infusion to treat children with systemic lupus…
    Read More…

    29 Apr
  5. AstraZeneca and MSD receive positive opinion for Lynparza

    AstraZeneca and MSD have received a positive opinion for Lynparza (olaparib) as a first-line maintenance treatment of BRCA-mutated advanced ovarian…
    Read More…

    29 Apr
  6. Boehringer Ingelheim files for regulatory approval of nintedanib

    Boehringer Ingelheim has filed regulatory submissions with the Food and Drug Administration (FDA) and European Medicines Agency (EMA) for approval…
    Read More…

    19 Mar
  7. Blackstone to acquire anti-rheumatism drugs maker Ayumi Pharmaceutical

    Blackstone’s private equity funds have signed a definitive agreement to acquire Japan-based anti-rheumatism drugs manufacturer Ayumi Pharmaceutical from Unison Capital…
    Read More…

    18 Mar
  8. AstraZeneca secures ODD from FDA for saracatinib to treat IPF

    AstraZeneca has secured orphan drug designation (ODD) from the US Food and Drug Administration (FDA) for its potential new medicine,…
    Read More…

    18 Mar
  9. P&G completes Merck’s Consumer Health unit acquisition for $3.8bn

    Procter & Gamble (P&G) has completed its acquisition of Merck’s Consumer Health business in a €3.4bn ($3.8bn) deal. The acquisition…
    Read More…

    3 Dec
  10. US scientists reveal new gene therapy for Parkinson’s disease

    Scientists from Feinstein Institute for Medical Research in the US have revealed that a gene therapy called AAV2-GAD for Parkinson’s…
    Read More…

    30 Nov
Close
Close
Close

Go Top